Pharma Focus Asia

Repligen

LATEST NEWSRead more...

26

Jun 2024

Lilly and OpenAI Collaborate on Developing New Treatments for Drug-Resistant Bacteria

Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance

26

Jun 2024

Junshi Biosciences Receives Approval for Toripalimab as a First-Line Therapy for Advanced Triple-Negative Breast Cancer

Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration

26

Jun 2024

Porton Advanced Launches MaxCyte ExPERT GTx Flow Electroporation System to Enhance Cell and Gene Therapy Offerings

Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China

25

Jun 2024

Biond Biologics Begins Phase 1 Clinical Trial, Administers First Dose of BND-35

Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient at the Institute of Oncology Davidoff Center Rabin...

25

Jun 2024

GSK's Omjjara (Momelotinib) Receives Approval in Japan for Treating Myelofibrosis

GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type

Solovpe

press releasesRead more...

26

Jun 2024

Hyundai Bioscience succeeds in developing 'Multi-treatment for mosquito-borne viral infections' including Dengue Fever

Hyundai Bioscience which is preparing for a dengue fever basket clinical trial in Brazil announced on the th that it has successfully developed a multitreatment drug for mosquitoborne viral infections

26

Jun 2024

Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy

Capricor Therapeutics a biotechnology company developing transformative cell and exosomebased therapeutics for the treatment of rare diseases today announced

26

Jun 2024

Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus

Charles River Laboratories International Inc and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract development and manufacturing

25

Jun 2024

Bota Bio's Biomanufacturing Technology is Commercialized at NHU with A Successful Strategic Partnership Established

Bota Bio a global industrial biotechnology company specializing in sustainable biomanufacturing solutions and NHU a global leader in the fine chemical industry have announced the successful commercialization

25

Jun 2024

Sun Pharma Completes Taro Merger

Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd with its subsidiary As part of this merger Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliate...

25 - 27

Jun 2024

3rd World ADC Asia

Incheon, South Korea

25 - 26

Jun 2024

Asia Healthcare Week (AHW)

Suntec Convention & Exhibition Centre, Singapore

26 - 27

Jun 2024

Future Labs

Basel, Switzerland

26 - 27

Jun 2024

29 - 30

Jun 2024

30 - 01

Jul 2024

Inalab 2023

Jakarta Barat, Indonesia

Cytiva - Supor Prime filters
MFA + MMA 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 2

    Incipient Biopharmaceutical Claims of Milk Derived Exosomes

    Rakesh Kumar Tekade

    Associate Professor, NIPER-Ahmedabad

    Nupur Vasdev

    Pursuing PhD in Pharmaceutics, NIPER-Ahmedabad

    Manisha Choudhary

    Pursuing M.S. (Pharm) in Pharmaceutics, NIPER-Ahmedabad

    Suryanarayana Polaka

    Pursuing PhD, NIPER-Ahmedabad

    Kiran Kalia

    Director and Professor, NIPER-Ahmedabad

KNOWLEDGE BANK

  • Interviews

    Powder Systems Limited

    Tendering Manager Asia-Pacific

    Powder Systems Limited PSL has been exporting its technology to the AsiaPacific market since and a growing number of turnkey installations are to be commissioned in this region in the future To support the demand PSL has committed to further investment in AsiaPacific APAC by opening an engineering and sales office in Singapore This addition to PSL APAC will reinforce the fast growing activities c...
  • Articles

    Smart Polymeric Nanocomposites for Cancer Therapeutics

    Globally cancer is the second most prevalent healthcare issue following cardiovascular Conventional methods such as chemotherapy and radiotherapy have several detrimental side effects without guaranteed permanent recovery In the last few decades efforts have been made by introducing nanotechnology to cancer therapeutics

  • White Papers

    The Need For Adaptive Trial Design In Oncology Studies

    Trial research needs to account for increased complexity and competition when recruiting patients in cancer studies Patients and oncologists have more choices than ever for the placement of qualified study participants Not only are treatments more specialised but the industry

EDITORIAL SECTION